HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN COMPLEXATION, WITH GLUTETHIMIDE

被引:0
|
作者
ELGENDY, GA
ELGENDY, MA
机构
关键词
GLUTETHIMIDE; DI-O-METHYL-BETA-CYCLODEXTRIN; INCLUSION COMPLEX; PHASE SOLUBILITY DIAGRAM; DISSOLUTION PROFILE; THERMAL ANALYSES; NMR SPECTROSCOPY; STABILITY CONSTANT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hypnotic glutethimide (GTI) is sparingly soluble and in the same time decomposes readily in alkaline solutions. Therefore, the inclusion complexation of GTI with heptakis (2,6-di-O-methyl)-beta-cyclodextrin (DMCD) was undertaken for improving its solubility and stability characteristics. Inclusion complexation of DMCD with GTI in aqueous solution and in solid phases was confirmed by the solubility method, X-ray diffractometry, nuclear magnetic resonance spectroscopy, infrared spectroscopy, and differential scanning calorimetry (DSC). The solubility curve of GTI-DMCD system was a typical A(L) type curve, and the apparent stability constant, K(c), was calculated from the slope and intercept of the solubility diagram as 631 M-1. The solid complexes of GTI with DMCD in 1 : 1 molar ratio were prepared by grinding and coprecipitation methods. The dissolution rate of GTI from the inclusion complex was much more rapid than that of the GTI alone since, after 10 min, the dissolved amount of GTI was about 8% while the corresponding amounts were 52, 78 and 97% for the physical mixture, ground mixture and coprecipiate, respectively. The enhanced dissolution may be due to the increase in solubility and decrease in crystallinity of the drug by the complexation, as expected from solubility study and X-ray diffractometry. The effect of DMCD on the alkaline hydrolysis of GTI was investigated at 30, 40 and 50-degrees-C. It was found that the degradation of GTI follows second-order kinetics in absence and presence of DMCD as is evident from the linear second-order plots. The inclusion with DMCD retards the decomposition in all cases. Stability constant, and rate constant of the complexes were determined kinetically on the basis of 1 : 1 inclusion complex formation.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 50 条
  • [1] STABILIZATION OF AN ANTHRAPYRAZOLE ANTITUMOR AGENT, DUP-937, ON COMPLEXATION WITH HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN IN AQUEOUS-SOLUTION
    RAGHAVAN, K
    NEMETH, G
    GRAY, D
    HUSSAIN, MA
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1994, 12 (10) : 1259 - 1264
  • [2] THERMAL-BEHAVIOR OF GROUND MIXTURES OF HEPTAKIS (2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN AND BENZOIC-ACID
    HANAWA, T
    YONEMOCHI, E
    OGUCHI, T
    NAKAI, Y
    YAMAMOTO, K
    JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY, 1993, 15 (01): : 91 - 101
  • [3] Experimental and theoretical studies on the inclusion complexation of syringic acid with α-, β-, γ- and heptakis(2,6-di-O-methyl)-β-cyclodextrin
    Song, Le Xin
    Wang, Hai Ming
    Xu, Peng
    Yang, Yan
    Zhang, Zi Qiang
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, 56 (04) : 468 - 474
  • [4] Inclusion phenomena of clove oil with α-, β-, γ- and heptakis (2,6-di-O-methyl)-β-cyclodextrin
    Song, L. X.
    Xu, P.
    Wang, H. M.
    Yang, Y.
    NATURAL PRODUCT RESEARCH, 2009, 23 (09) : 789 - 800
  • [5] Host-Guest Complexation of Olmesartan Medoxomil by Heptakis(2,6-di-O-methyl)-β-cyclodextrin: Compatibility Study with Excipients
    Man, Dana Emilia
    Nitu, Ema-Teodora
    Temereanca, Claudia
    Sbarcea, Laura
    Ledeti, Adriana
    Ivan, Denisa
    Ridichie, Amalia
    Andor, Minodora
    Jijie, Alex-Robert
    Barvinschi, Paul
    Rusu, Gerlinde
    Varut, Renata-Maria
    Ledeti, Ionut
    PHARMACEUTICS, 2024, 16 (12)
  • [6] Formation, characterization and pH dependence of rifampicin: heptakis( 2,6-di-O-methyl)-β-cyclodextrin complexes
    Angiolini, Lorenzo
    Agnes, Marco
    Cohen, Boiko
    Yannakopoulou, Konstantina
    Douhal, Abderrazzak
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 531 (02) : 668 - 675
  • [7] Inclusion interaction of chloramphenicol and heptakis (2,6-di-O-methyl)-β-cyclodextrin: Phase solubility and spectroscopic methods
    Shi, Jie-Hua
    Zhou, Ya-fang
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2011, 83 (01) : 570 - 574
  • [8] Compatibility studies with pharmaceutical excipients for aripiprazole–heptakis (2,6-di-O-methyl)-β-cyclodextrin supramolecular adduct
    Ionuț-Mihai Tănase
    Laura Sbârcea
    Adriana Ledeţi
    Paul Barvinschi
    Denisa Cîrcioban
    Gabriela Vlase
    Renata-Maria Văruţ
    Ionuţ Ledeţi
    Journal of Thermal Analysis and Calorimetry, 2020, 142 : 1963 - 1976
  • [9] Crystal structures and molecular dynamics studies of the inclusion compounds of β-citronellol in β-cyclodextrin, heptakis(2,6-di-O-methyl)-β-cyclodextrin and heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin
    Fourtaka, Katerina
    Christoforides, Elias
    Mentzafos, Dimitris
    Bethanis, Kostas
    JOURNAL OF MOLECULAR STRUCTURE, 2018, 1161 : 1 - 8
  • [10] Compatibility studies with pharmaceutical excipients for aripiprazole-heptakis (2,6-di-O-methyl)-β-cyclodextrin supramolecular adduct
    Tanase, Ionut-Mihai
    Sbarcea, Laura
    Ledeti, Adriana
    Barvinschi, Paul
    Circioban, Denisa
    Vlase, Gabriela
    Varut, Renata-Maria
    Ledeti, Ionut
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2020, 142 (05) : 1963 - 1976